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The traditional management of infected prosthet-
ic arterial grafts includes total graft excision, over-
sewing or ligation of the involved arteries, debride-
ment of infected tissue, and revascularization when
necessary to achieve limb salvage.1 However, when
maintaining patency of an involved artery is essential
for limb salvage or to allow healing of an amputation,
placement of an autologous tissue patch in the infect-
ed field has been advocated. We have observed a dis-
turbingly high rate of autologous tissue patch rup-
ture when we attempted this technique.2 An alterna-
tive method of treatment includes subtotal excision
of the infected prosthetic graft and oversewing a
small remnant or “patch” of graft at the arterial anas-
tomosis.3 We present our updated results of infected
prosthetic grafts treated by means of this method.
PATIENTS AND METHODS
Between January 1, 1978, and December 31,
1998, we treated 53 wounds involving 45 infected
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prosthetic grafts in 42 patients by means of subtotal
graft excision and oversewing of a residual 2- to 3-mm
graft remnant (patch) at an intact arterial anastomosis
(Table I). The procedures were performed in 22 men
and 20 women, ranging in age from 34 to 87 years
(average age, 69 years). Indications for the bypass
graft that ultimately became infected were limb sal-
vage in 40 cases and disabling claudication in five
cases. The vessels involved were 41 common femoral,
five deep femoral, three axillary, two popliteal, one
common iliac, and one external iliac artery. Graft
remnants were polytetrafluoroethylene in 51 cases
and Dacron in two cases. Of the 45 grafts, 31 were
occluded and 14 were patent. All 42 patients had
signs of local wound and graft infection, including
purulent drainage, a sinus tract, or erythema involving
a previous incision overlying a prosthetic arterial graft.
Subtotal graft excision and oversewing of a patch
remnant was performed to treat an infected prosthet-
ic graft only when these criteria were fulfilled: (1)
maintaining patency of the underlying artery was crit-
ical to achieving limb salvage or healing an amputa-
tion; (2) the anastomosis was intact without pseudo-
aneurysm; and (3) the integrity of the underlying
artery was satisfactory. Alternatively, the artery was
oversewn or ligated when maintaining patency of the
artery was not considered essential, the anastomosis
was disrupted, or the infectious process significantly
weakened the underlying artery.
When the underlying artery was encased in dense
scar tissue and dissection was considered to be par-
ticularly hazardous, a Satinsky clamp was applied to
the base of the graft near the intact anastomosis, the
graft was transected 2 to 3 mm above the clamp, and
the graft remnant was oversewn with a double-run-
ning layer of 5-0 or 6-0 polypropylene suture, leav-
ing a small cuff or patch (Figs 1 and 2). In 37 of the
45 grafts, the entire graft was excised, except for an
oversewn patch at one anastomosis. In the other
eight cases, patch remnants were oversewn at both
anastomoses, because maintaining patency of both
arteries was considered important, and the entire
intervening graft was excised. When the infection
was found by means of preoperative clinical and
radiologic evaluation to be confined to one anasto-
motic segment of the graft, the other uninvolved
anastomotic segment of graft was excised, and the
wound was closed; then the next uninvolved seg-
ment of graft was excised, and so on until the infect-
ed segment of graft was reached.
All infected tissue in the involved wound was ini-
tially widely excised in the operating room, and
repeated debridement of necrotic tissue was per-
formed as necessary, until there was no further
drainage from the wound and healthy granulation
tissue was present. Antibiotic-soaked wet-to-dry
dressings were changed at least three times daily.
Appropriate intravenous antibiotics were adminis-
tered for at least 1 week, until there was no further
clinical evidence of infection. Wound cultures for
aerobic and anaerobic bacteria and fungi were
obtained in all patients (Table II).
Secondary bypass grafting procedures were per-
formed as needed to achieve limb salvage. The fol-
low-up period in surviving patients averaged 32
months (range, 1 to 218 months).
RESULTS
No complications directly attributable to pros-
thetic patch remnants were found in 92% of cases
(49 of 53 cases). Two infected pseudoaneurysms
developed 8 and 34 months after surgery. These
patients were treated by means of excision of the
oversewn prosthetic patch, oversewing of the
involved artery, and extra-anatomic revasculariza-
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Table II. Bacteriology
Gram-positive bacteria
Staphylococcus aureus 14
Staphylococcus epidermidis 12
Streptococcus faecalis 7
Streptococcus viridans 6
Corynebacterium diptheroides 1
Corynebacteria 1
Gram-negative bacteria
Pseudomonas aeruginosa 8
Escherichia coli 4
Proteus mirabilis 4
Enterobacter 4
Serratia marcescens 3
Acinetobacter 2
Bacteroides fragilis 2
Aerobacter 1
Klebsiella oxytoca 1
Morganella morganii 1
More than one bacterium were cultured from several wounds.
Table I. Types of infected grafts
Type Number
Femorodistal 30
Above-knee popliteal 6
Below-knee popliteal 5
Infrapopliteal 19
Axillofemoral 5
Femorofemoral 5
Aortobifemoral 3
Iliofemoral 2
tion. These two patients died of cardiac causes 3 and
84 months after excision of the prosthetic patch.
Two patients with non-healing wounds after 1 and 2
weeks of aggressive wound debridement and local
wound care underwent excision of the prosthetic
patch. One patient underwent placement of a vein
patch, with apparent healing of the wound. This
patient was lost to follow-up after hospital discharge.
The other patient was treated by means of primary
closure of the involved artery, which was complicat-
ed by arterial hemorrhage 3 weeks later. This patient
required arterial ligation proximal and distal to the
arteriotomy and an extra-anatomic vein bypass graft-
ing procedure.
Six of 42 patients (14%) died during hospitaliza-
tion (three of cardiac complications and three of sepsis
with multiple organ failure). None of the deaths were
necessarily attributable to patch remnant oversewing,
because the wounds were healing well at the time of
death, although the prosthetic remnant potentially
may have led to persistent infection. Although we did
not believe that the small remnant of prosthetic graft
was contributing to the septic process, the complica-
tion rate of oversewn prosthetic patches was 13% (7 of
53 cases), when the three deaths caused by sepsis are
included with the four wound complications.
In 26 of 52 threatened limbs, patch remnant
oversewing led to limb salvage without the need for
secondary revascularization. In 16 patients, sec-
ondary bypass grafting procedures were necessary to
achieve limb salvage. Two patients who required
amputation died during hospitalization, and the
amputation wounds of eight patients successfully
healed when prosthetic patch remnant closure had
maintained flow through a key collateral vessel and
no other secondary revascularization was deemed
possible. Long-term limb-salvage rates were not cal-
culated, because some patients were treated with
JOURNAL OF VASCULAR SURGERY
Volume 31, Number 2 Calligaro et al 247
Fig 1. A, Schematic showing an infected groin wound with an intact prosthetic graft anasto-
mosis to the common femoral artery. B, The same wound after aggressive operative debride-
ment of all infected tissue, subtotal excision of the graft, and oversewing of a 2- to 3-mm pros-
thetic graft remnant or patch.
A B
secondary bypass grafting procedures at the time of
management of the infected grafts, whereas other
patients were treated by means of patch remnant
oversewing without secondary revascularization. 
Staphylococcus aureus and S epidermidis were the
most common gram-positive bacteria cultured, and
Pseudomonas aeruginosa was the most common
gram-negative bacteria cultured (Table II). In the
two wounds that developed late pseudoaneurysms,
one wound cultured Proteus mirabilis, and the other
cultured Serratia marcescens. In the two wounds
that failed to heal, one cultured S aureus, and the
other cultured S marcescens.
DISCUSSION
Leaving oversewn prosthetic patch remnants to
treat infected prosthetic arterial grafts is a controver-
sial strategy for several reasons. There is universal
agreement that the optimal strategy to ensure that
recurrent or persistent infection does not occur is
total excision of all infected prosthetic material.
There is also general agreement that the safest
method of managing the involved artery in an
infected field after graft excision is ligation or over-
sewing of the artery proximal and distal to the pre-
vious anastomosis. 
However, there is a high limb-loss rate associat-
ed with routine total graft excision and arterial liga-
tion or oversewing.4 In many patients with infected
arterial grafts, maintaining patency of the artery at
the infected site is essential for limb salvage or heal-
ing an amputation. In a patient with an infected
common femoral-to-distal arterial bypass graft, orig-
inally placed to heal a small area of ischemic ulcera-
tion or gangrene, maintaining patency of the com-
mon and deep femoral artery may be sufficient to
achieve limb salvage, without the need for a sec-
ondary revascularization procedure. In cases in
which a secondary bypass graft would be necessary
to achieve limb salvage but is not possible because of
the lack of a suitable outflow artery or appropriate
conduit, preservation of the deep femoral artery may
be critical to healing the amputation. Therefore, the
patch remnant technique may improve limb-salvage
rates or allow for more distal amputations than
methods that involve arterial interruption.
A more commonly accepted method to preserve
the underlying artery in prosthetic graft infections is
total graft excision with the placement of an autolo-
gous tissue patch by using vein or an endarterec-
tomized arterial segment.5 However, when we have
used this strategy, rupture of the autologous tissue
patch has occurred.2 We have a much smaller experi-
ence with the use of vein patches, compared with
oversewn prosthetic patch remnants, to treat infected
arterial grafts. When vein patches were placed in an
infected field, three of seven patches eventually rup-
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Fig 2. A, An operative photograph of an oversewn pros-
thetic patch remnant in a groin wound with surrounding
granulation tissue. B, A follow-up photograph of the same
wound after granulation tissue has covered the prosthetic
patch remnant.
A
B
tured. In one instance, the vein patch was placed to
treat a disrupted anastomosis. We have rarely used
endarterectomized segments of occluded superficial
femoral artery as patches in infected fields. Although
we believe that the complication rate associated with
oversewn prosthetic patch remnants is acceptable and
possibly represents improved results compared with
autologous patches, the use of oversewn prosthetic
remnants is a simpler and less time-consuming treat-
ment in these frequently critically ill patients with
densely scarred wounds. These ruptures occurred at
both the anastomosis and the center of the autolo-
gous patch. We believe that total excision of the pros-
thetic graft, taking down the anastomosis, and sutur-
ing in a new autologous patch at the previous anas-
tomotic site that is exposed to bacteria may lead to
more significant arterial wall weakening than leaving
the original anastomosis and artery intact. In addi-
tion, virulent bacteria, such as Pseudomonas, can
degrade autologous tissue through the action of elas-
tase and collagenase and lead to autologous patch
weakening and rupture.6,7 The same problem with
placing an autologous patch holds for placing a new
prosthetic patch, namely that a new arterial anasto-
mosis will need to be performed.
A second advantage of leaving an oversewn pros-
thetic patch remnant is that the difficult and time-
consuming dissection of the underlying artery in
densely scarred wounds can usually be avoided.
Placing a new patch usually requires complete dis-
section of the artery with proximal and distal con-
trol, although balloon control may, in some cases,
obviate the need for such dissection or full arterial
mobilization in these infected wounds.8 These
maneuvers can be associated with nerve, venous, or
arterial injury and can result in permanent neuropa-
thy or major arterial or venous bleeding. Patients
with infected arterial grafts are often elderly and
have multiple medical problems. A quicker, less-
morbid procedure is advantageous. The placement
of a new prosthetic patch has the same disadvantages
as an autologous patch.
We and other authors have previously reported
success with a controversial strategy to treat focal infec-
tions of prosthetic arterial grafts, complete graft
preservation.3,7,9,10 This treatment should only be
considered when the patient is not septic because of
the graft infection, the anastomosis is intact, only a
small segment of the graft is infected, and the graft is
patent. In the 14 patent grafts in this series, the pres-
ence of at least one of these other criteria prevented
the attempted complete graft preservation, and the
patients were instead treated by means of subtotal graft
excision with an oversewn prosthetic patch. In addi-
tion, when Pseudomonas is cultured from the wound,
complete graft preservation should probably not be
attempted because of the virulent nature of this organ-
ism, although we have made exceptions when the only
alternative was certain amputation.7 A somewhat dif-
ferent set of criteria must be kept in mind when con-
sidering subtotal graft excision and leaving an over-
sewn prosthetic patch remnant. The only absolute
contraindication to this latter strategy is a disrupted
anastomosis. In these cases, the only option is total
excision of the infected graft and oversewing or liga-
tion of the underlying artery with or without revascu-
larization. Closing a disrupted infected anastomosis
and leaving a patch or all of the graft will routinely
result in recurrent bleeding and is a poor strategy.
Subtotal graft excision and leaving an oversewn pros-
thetic patch remnant is most appropriate when trying
to maintain patency of arteries that may be critical to
limb salvage or amputation healing. Pseudomonas was
cultured from eight wounds treated by means of over-
sewn prosthetic patch remnants. Although the results
when leaving an oversewn prosthetic patch in wounds
that cultured Pseudomonas were good, our earlier poor
results with complete graft preservation in the setting
of this bacteria makes us very cautious in attempting to
leave even a prosthetic patch in wounds in which
Pseudomonas is cultured. Currently, we would only
leave a prosthetic remnant in an infected wound that
cultured Pseudomonas when amputation would be the
certain outcome if the artery was ligated or oversewn.
Although the placement of an autologous patch in a
wound infected by Pseudomonas may be more likely to
heal than the leaving of a prosthetic patch, we are con-
cerned that autologous patches may be more likely to
rupture in the presence of such a virulent organism.6,7
Although they were not used in this series, mus-
cle flaps are frequently used to achieve successful
wound healing when attempting complete preserva-
tion of infected grafts. Muscle flaps were not used to
help preserve oversewn prosthetic patch remnants
because many patients were debilitated or too criti-
cally ill to return to the operating room for another
major operation, the wounds were still draining or
did not have enough healthy granulation tissue to
accept a flap, or the wounds were granulating well a
few days after wound debridement with the pros-
thetic patch remnant almost covered. Patients were
frequently discharged after granulation tissue cov-
ered the graft, but before the entire wound had
completely healed. Visiting nurses provided wound
care and daily dressing changes, and patients were
examined during frequent office visits. 
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Prosthetic patch remnants are a useful adjunct
that simplify the management of selected prosthetic
graft infections. Our long-term results suggest that
this technique is associated with a low incidence of
wound complications and late recurrent infection. 
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Dr Patrick J. O’Hara (Cleveland, Ohio). Dr Zarins,
Dr Green, Dr Cronenwett, members, and guests. 
Dr Calligaro and his colleagues are to be congratulated
on achieving impressive results in a group of patients who,
most of us would agree, are difficult to treat. They retro-
spectively examined a group of 42 patients with 45 infected
prosthetic grafts, accumulated in a 20-year period, whom
they were able to treat with partial graft excision, leaving a
small remnant of prosthetic cuff to act as a patch angioplas-
ty to preserve arterial continuity. These patients were care-
fully selected, by using criteria that seems designed to
exclude anastomotic involvement, thus yielding infections
involving the shaft of the graft. Despite this selection, how-
ever, hospital mortality was still 14%, and, notably, half the
early deaths were caused by multisystem failure and sepsis.
Four other patients, another 10%, had recurrent graft sepsis
that required reoperation for complete graft excision. This
yields a combined sepsis-related early mortality and mor-
bidity rate of approximately 17%.
Although I would agree with the authors that it is
sometimes possible to leave some uninfected synthetic
material in place, in practice, I’ve often found it difficult to
choose appropriate patients for this procedure, because
often the infection begins in the groin and involves the
anastomosis. In our own experience with infrainguinal syn-
thetic graft infections at the Cleveland Clinic, we found that
82% of patients were treated with incomplete graft excision
and required subsequent operation for the control of sepsis,
whereas only 13% of complete graft excisions required sub-
sequent operation for the control of sepsis—a difference
that was significant. Furthermore, we observed an 18% early
postoperative mortality rate, and 58% of these deaths were
related to uncontrolled sepsis, all occurring among the
group in which limb salvage was still being attempted. 
These considerations lead to three questions. 
First, on the surface, your results with incomplete
graft excision seem much more optimistic than ours.
However, our report includes all graft infections that we
treated. According to your manuscript, during the study
period you did treat some other patients with complete
graft excision. Therefore, what proportion of your overall
experience does the selected subset of patients in this
report represent? 
Second, I think that some patients may live in sym-
biosis with bacterial colonization of their synthetic mate-
rial. Do you think that your patients with retained graft
segments require long-term suppressive antibiotic cover-
age, perhaps for life? 
Finally, my main concern is how the authors can be
certain that the deaths of the three patients who died of
sepsis and multisystem organ failure, representing fully
50% of the early mortality in this series, were not related
to persisting infection in the graft remnant, although the
wounds looked good? 
Even with the authors’ acknowledged expertise in this
area, they arguably failed to control sepsis in one of six
patients in this series. Consequently, I would advise caution
in the application of this method, and, when it is used, care-
ful and close late follow-up in an extended period is required. 
I would like to thank the authors for providing me
with a copy of the manuscript, and I’d like to thank the
Society for the privilege of the floor.
DISCUSSION
Dr Keith D. Calligaro. Thank you, Dr O’Hara. 
First, I’d like to point out that, in most of these cases,
purulent fluid came very close or actually involved the
anastomosis. These were not cases that involved just the
body of the graft. Granted, in some cases, the infectious
process seemed to stop just short of the anastomosis, but
in most the anastomosis was exposed. In all cases, the
anastomosis was intact, but there was still pus near the
anastomosis. 
We are aware of your results at the Cleveland Clinic
with incomplete graft excision. Quite frankly, I’m just not
sure whether the way those patients were handled would
have been the way we would have handled them at our
institution. Maybe some of your patients who had occlud-
ed grafts were treated with an incomplete graft excision,
and rather long segments of occluded, infected graft were
left in place. We would never do that. 
In answer to your questions, this experience probably
represents approximately one third of all of the infected
prosthetic grafts managed at both institutions, maybe less.
The reason it’s not more is that when the arteries were not
deemed critical, they were either ligated or handled in
other ways. Also, the other criteria had to be fulfilled.
When a patient came in with an infected pseudoaneurysm,
they were not treated this way. 
In answer to your second question about the duration
of intravenous antibiotic administration, we suggest that it
be given for at least 1 week. Most patients were given
intravenous antibiotics for at least 6 weeks. As far as life-
long intravenous, or even oral, antibiotics are concerned,
we do not feel that they are necessary. 
In answer to the third question about whether this 2-
mm patch of the prosthetic graft accounted for persistent
sepsis, I find that somewhat hard to believe, to be frank.
When there is healthy granulation tissue in the wound and in
the next week or so you see healthy granulation tissue close
over this small patch of graft and no drainage at all, it’s hard
for me to accept that the patch is the cause of persistent sep-
sis. The reason I think these patients died of sepsis is they
came in septic. They mainly died of multiple organ failure,
meaning pneumonia or renal failure or other problems, and
it’s hard to attribute that to a small segment of patch.
Dr Michael T. Watkins (Boston, Mass). Dr Calligaro,
I enjoyed your talk. I have a question. 
How did you get the granulation tissue to develop in
the wounds? That is, did you use any adjunct procedures,
such as a rectus or a sartorius flap?
Dr Calligaro. Regrarding granulation tissue, I can’t
emphasize enough the aggressive nature of wound debride-
ment that you must use to satisfactorily heal these wounds. 
Muscle flaps were only used in two patients, and they
weren’t really muscle flaps. They were sartorius myoplasties,
in which the muscle is just moved over to cover the patch a
little bit.
Dr Linda M. Reilly (San Francisco, Calif ). I just have
a couple of questions from the traditionalist group.
You emphasize that it’s important to widely resect all
the involved infected tissue. How can you do that if you
don’t know the location of the anastomosis and don’t have
that perianastomotic region dissected out to protect it? 
Second, how do you determine specifically that the
anastomosis is not involved if you have not exposed it
thoroughly at the time of surgery? 
Third, did you mention the interval between the
placement of the graft and the appearance of infection in
your patient group? If you did, I missed it. Could you tell
us what the rate of patch disruption was in the patients
who prompted you to move to this alternate technique?
And if so, was it a long time ago, before the recognition
of the importance of wide resection of the infected tissue
and the use of other adjunctive techniques? 
Fourth, could you comment about the possibility that
having a little short stump of graft with thrombus in it
actually is a disadvantage for eradicating infection locally? 
Finally, I think that you would probably be wiser to
just accept the fact that if you have patients dying of sep-
sis in the perioperative period when you’ve treated them
for infection, they should be considered as perioperative
deaths related to your technique.
Dr Calligaro. Thank you, Dr Reilly. 
Again, I want to clarify something you may have
missed. We knew exactly where the level of the anastomo-
sis was in every single case. This graft was clamped, literal-
ly, a millimeter or two above the anastomosis. So, clearly,
we saw the level of the anastomosis in every single case. 
The onset of infection has ranged from days to
months and years later. 
Third, the vein patch disruption rate that we’ve previ-
ously noted was a very limited series. But, nonetheless,
that’s why we stopped it. There were three vein patch rup-
tures in the seven cases on which we’ve tried it. I would
welcome others to report their data. 
Fourth, I still do not accept that oversewing this very
small prosthetic patch was the cause of persistent sepsis.
We’ve all seen patients who have severe infection. It’s clear
that they’re dying of multiple organ failure, because
they’ve come in extremely sick. I can’t imagine that leav-
ing a 2-mm patch of prosthetic graft is causing consistent
bacteremia.
There is minimal thrombus in there, because the graft
is essentially oversewn as a patch, not as a segment of graft.
Dr William D. Turnipseed (Madison, Wis). Approx-
imately three quarters of your patients were pretty easy to
treat because they had occluded grafts. Basically, you
removed the grafts and preserved collaterals. I totally
agree with this concept. 
The problem that I have is that 14 patients in your
group apparently had intact anastomoses, functional
grafts, and perigraft infection. These grafts frequently can
be salvaged by alternative techniques, either direct graft
preservation or graft replacement and coverage with
myocutaneous or other biological flaps. I wonder if you
would comment on why graft salvage was not attempted
in these patients.
Dr Calligaro. Yes, Dr Turnipseed, in answer to your
first question about the occluded grafts, you’re right.
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Those were relatively easier to treat. But again, the point
was that the grafts were occluded. And as you alluded, we
still needed to maintain patency of the artery to achieve
limb salvage; that’s why the remnants acted as a patch. 
Second, we have published a study on graft preserva-
tion for patients with infected prosthetic grafts. In these
42 patients, we did not attempt that strategy, because the
entire graft was either bathed with pus or because of other
reasons, such as the patients were septic.
Dr Peter Gloviczki (Rochester, Minn). Keith, it looks
like you only used a few polyester grafts, so I’m wonder-
ing whether you preferentially used this technique for the
treatment of infected polytetrafluoroethylene grafts?
My second question concerns the graft material that we
should use in an infected field. I presume most of your
infrainguinal revascularization patients did not have autolo-
gous vein. So, what do you recommend that we use? Should
we use a rifampin-soaked polyester graft or maybe a cryo-
preserved artery or cryopreserved vein graft? 
Dr Calligaro. Yes, the numbers were very small for
oversewing a Dacron graft. Those were aortobifemoral
grafts. We believe it still would work for that type of graft,
but the numbers are admittedly small. 
For revascularization, obviously, if we can harvest arm
vein or any other vein, we would prefer to use that, but still
place it through an extra-anatomic bypass graft. If vein is not
available, then placing another prosthetic graft through an
extra-anatomic bypass graft is our choice. And when con-
cerned about bacteremia, we favor a rifampin-coated graft. 
Thank you.
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